Published in Blood Weekly, February 15th, 2007
Throughout 2006 the company made significant progress towards its goal of establishing the use of its CardioQ system as a standard of care in the monitoring and management of people undergoing major surgery. As a result, the directors anticipate that sales for the year will be in excess of UKP 3.5 million.
In August 2006 the British Journal of Surgery published the results of a major new randomised controlled clinical trial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.